A61K 38/2066
Il-10
Official title: {il-10}
A61K38/2066 (Il-10) appears on 299 US grants and 577 published applications in this corpus.
Search patents in A61K- Granted patents
- 299
- Published applications
- 577
- Assignees
- 293
- Inventors
- 943
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 7 | 0 |
| 2001 | 3 | 2 |
| 2002 | 7 | 12 |
| 2003 | 2 | 13 |
| 2004 | 4 | 13 |
| 2005 | 1 | 11 |
| 2006 | 6 | 20 |
| 2007 | 5 | 7 |
| 2008 | 5 | 14 |
| 2009 | 1 | 19 |
| 2010 | 3 | 14 |
| 2011 | 6 | 27 |
| 2012 | 8 | 12 |
| 2013 | 7 | 16 |
| 2014 | 18 | 26 |
| 2015 | 17 | 40 |
| 2016 | 16 | 35 |
| 2017 | 22 | 26 |
| 2018 | 17 | 34 |
| 2019 | 22 | 38 |
| 2020 | 25 | 29 |
| 2021 | 16 | 32 |
| 2022 | 25 | 34 |
| 2023 | 10 | 27 |
| 2024 | 11 | 24 |
| 2025 | 12 | 33 |
| 2026 | 12 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immunocytokines for treatment of autoimmune and inflammatory conditions9 Jun 2026US 12,649,782 B2Horizon Therapeutics Ireland DAC
- Composition for treating pain26 May 2026US 12,636,346 B2Kolon Life Science, Inc.
- Aryl pladienolides for the treatment of neoplastic disorders12 May 2026US 12,622,905 B2Eisai R&D Management Co., Ltd.
- Compositions and methods of use of interleukin-10 in combination with immune check-point pathway inhibitors31 Mar 2026US 12,589,134 B2Eli Lilly and Company
- CD4+ T cells expressing IL-10 and chimeric antigen receptors and uses thereof17 Mar 2026US 12,576,150 B2Tr1x, Inc.
- Targeted lipid nanoparticles for treating central nervous system injuries8 Oct 2026US 2026/0306665 A1Wisconsin Alumni Research Foundation
- Treg therapy10 Sep 2026US 2026/0263556 A1Quell Therapeutics Limited
- Method and composition for preventing or treating myopia20 Aug 2026US 2026/0240925 A1Tsubota Laboratory, Inc.
- Stem cells for transplantation and manufactauring method therefor20 Aug 2026US 2026/0240952 A1National Center of Neurology and Psychiatry
- Certain aryl pladienolide compounds and methods of use6 Aug 2026US 2026/0224560 A1Eisai R&D Management Co., Ltd.
Most cited
By later US patents
- B7-H1 and methods of diagnosis, prognosis, and treatment of cancer68US 7,892,540 B2Mayo Foundation for Medical Education and Research · 2011
- Compositions and methods for systemic inhibition of cartilage degradation67US 7,067,144 B2Omeros Corporation · 2006
- 2′,3′-dideoxynucleoside analogues for the treatment or prevention of Flaviviridae infections54US 7,772,208 B2Emory University · 2010
- Use of IL-10 to treat inflammatory bowel disease51US 5,368,854 ASchering Corporation · 1994
- Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use51US 6,800,287 B2Yeda Research and Development Co. Ltd. · 2004